Bristol-Myers Squibb Company;Université de Montréal
发明人:
BANVILLE, Jacques,RÉMILLARD, Roger,RUEDIGER, Edward H.,DEON, Daniel H.,GAGNON, Marc,DUBÉ, Laurence,GUY, Julia,PRIESTLEY, Eldon Scott,MAXWELL, Brad D.,WONG, Pancras C.,LAWRENCE, Michael R.,MILLER, Mich
申请号：
DK17172927
公开号：
DK3243826T3
申请日:
2013.04.24
申请国别(地区):
DK
年份:
2020
代理人:
摘要：
The present invention provides thiazole compounds of Formula I wherein W, Y, R 0 , R 2 , R 4 , R 5 , R 6 , R 7 , X 1 , X 2 , X 3 and X 4 are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.
